This inventor holds 5 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Daiichi Sankyo Company, Limited, Saitama Medical University, Lotte Co., Ltd.. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 462 
3 out of 34 
1 out of 59 
Years Active: 2016-2022
Title: Kenji Osawa: Innovator in Antibody Development
Introduction
Kenji Osawa is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of five patents to his name, Osawa's work focuses on innovative solutions for treating various medical conditions.
Latest Patents
One of Kenji Osawa's latest patents is the Anti-ALK2 antibody. This application provides an antibody that specifically binds to an ALK2 protein and has the activity of inhibiting BMP signal transduction mediated by ALK2. It also includes a method for producing the antibody and a pharmaceutical composition comprising the antibody, aimed at treating and/or preventing ectopic ossification, bone dysplasia, anemia, or diffuse intrinsic pontine glioma (DIPG).
Career Highlights
Throughout his career, Kenji Osawa has worked with notable institutions, including Saitama Medical University and Daiichi Sankyo Company, Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative medical therapies.
Collaborations
Kenji Osawa has collaborated with esteemed colleagues such as Takenobu Katagiri and Sho Tsukamoto. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Kenji Osawa's work in antibody development showcases his dedication to advancing medical science. His innovative patents and collaborations highlight his significant role in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile